Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
Holding GB:FAB?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 16, 2024 | Adrian Kinkaid Chief Executive Officer | xxxxxxxxxxxxx | £3508 |
| Sep 09, 2024 | Richard John Buick Chief Scientific Officer | xxxxxxxxxxxxx | £3110 |
| Sep 05, 2024 | Adrian Kinkaid Chief Executive Officer | xxxxxxxxxxxxx | £3804 |
| Jul 22, 2024 | Simon Douglas Douglas Chairman,director | xxxxxxxxxxxxx | £4815 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Fusion Antibodies Plc (GB:FAB)?
Currently, no data Available
What percentage of Fusion Antibodies Plc (GB:FAB) stock is held by institutional investors?
Currently, no data Available
What percentage of Fusion Antibodies Plc (GB:FAB) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Fusion Antibodies Plc (GB:FAB)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.